Thapsigargin: key to new host-directed coronavirus antivirals?

Despite the great success of vaccines that protect against RNA virus infections, and the development and clinical use of a limited number of RNA virus-specific drugs, there is still an urgent need for new classes of antiviral drugs against circulating or emerging RNA viruses. To date, it has proved...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaban, Mohammed Samer, Mayr-Buro, Christin, Meier-Soelch, Johanna, Albert, Benadict Vincent, Schmitz, M. Lienhard, Ziebuhr, John, Kracht, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013669/
https://www.ncbi.nlm.nih.gov/pubmed/35534355
http://dx.doi.org/10.1016/j.tips.2022.04.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013669/
https://www.ncbi.nlm.nih.gov/pubmed/35534355
http://dx.doi.org/10.1016/j.tips.2022.04.004

Ejemplares similares